We are live on ! Find out more
ASMB icon

Assembly Biosciences
ASMB

48 hedge funds and large institutions have $92.3M invested in Assembly Biosciences in 2015 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 18 increasing their positions, 7 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

157% more repeat investments, than reductions

Existing positions increased: 18 | Existing positions reduced: 7

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

8% less funds holding

Funds holding: 52 → 48 (-4)

22% less capital invested

Capital invested by funds: $118M → $92.3M (-$26M)

44% less first-time investments, than exits

New positions opened: 5 | Existing positions closed: 9

Holders
48
Holders Change
-4
Holders Change %
-7.69%
% of All Funds
1.26%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
5
Increased
18
Reduced
7
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
EC
EcoR1 Capital
California
+$1.92M
2
VAM
Visium Asset Management
New York
+$908K
3
William Blair & Company
William Blair & Company
Illinois
+$244K
4
Vanguard Group
Vanguard Group
Pennsylvania
+$208K
5
CC
Caxton Corporation
New Jersey
+$164K

Top Sellers

Rank Fund Capital Flow
1
HM
HealthCor Management
New York
-$3.05M
2
Morgan Stanley
Morgan Stanley
New York
-$536K
3
Millennium Management
Millennium Management
New York
-$240K
4
PP
PDT Partners
New York
-$207K
5
AQR Capital Management
AQR Capital Management
Connecticut
-$189K
Name Holding Trade Value Shares
Change 		Change in
Stake
EC
1
EcoR1 Capital
California
$15.8M +$1.92M +17,603 +11%
Jennison Associates
2
Jennison Associates
New York
$15.2M +$58.9K +541 +0.3%
VAM
3
Visium Asset Management
New York
$12.8M +$908K +8,334 +6%
O
4
OrbiMed
New York
$10.5M – – –
PA
5
Perceptive Advisors
New York
$5.97M – – –
QF
6
QVT Financial
New York
$3.62M – – –
Vanguard Group
7
Vanguard Group
Pennsylvania
$3.29M +$208K +1,906 +6%
BFA
8
BlackRock Fund Advisors
California
$2.89M +$95.2K +874 +3%
RSCM
9
Rock Springs Capital Management
Maryland
$2.79M – – –
PI
10
Putnam Investments
Massachusetts
$2.78M – – –
BIT
11
BlackRock Institutional Trust
California
$2.76M +$35.8K +329 +1%
Millennium Management
12
Millennium Management
New York
$2.66M -$240K -2,203 -7%
BBA
13
Baker Bros. Advisors
New York
$1.88M – – –
Fidelity Investments
14
Fidelity Investments
Massachusetts
$1.48M -$118K -1,083 -6%
Northern Trust
15
Northern Trust
Illinois
$1.31M +$67.4K +619 +4%
IHM
16
Iguana Healthcare Management
New York
$1.13M – – –
State Street
17
State Street
Massachusetts
$1.08M +$78.7K +722 +6%
Geode Capital Management
18
Geode Capital Management
Massachusetts
$649K +$9.15K +84 +1%
BIM
19
BlackRock Investment Management
Delaware
$390K +$980 +9 +0.2%
TCIM
20
TIAA CREF Investment Management
New York
$368K +$28.4K +261 +7%
Bank of New York Mellon
21
Bank of New York Mellon
New York
$344K – – –
William Blair & Company
22
William Blair & Company
Illinois
$344K +$244K +2,238 +141%
Dimensional Fund Advisors
23
Dimensional Fund Advisors
Texas
$311K – – –
California State Teachers Retirement System (CalSTRS)
24
California State Teachers Retirement System (CalSTRS)
California
$200K +$4.47K +41 +2%
TA
25
Teachers Advisors
New York
$159K – – –
1
2 3

ASMB Hedge Fund Activity: Q4 2015 in Review

48 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in Assembly Biosciences (ASMB) for Q4 2015, worth a combined $92.3M — down 22% from $118M a quarter earlier.

Sellers outnumbered buyers: 9 funds closed out of ASMB and 5 opened new positions — a net loss of 4 holders — while 7 trimmed existing stakes and 18 added.

The largest buyer was EcoR1 Capital, adding an estimated $1.92M. The largest seller was HealthCor Management, exiting entirely with an estimated $3.05M sold.

  • 48 institutional investors held Assembly Biosciences (ASMB) as of Q4 2015, down from 52 in Q3 2015.
  • Funds reported $92.3M of Assembly Biosciences stock for Q4 2015, down 22% quarter-over-quarter.
  • 5 funds opened new Assembly Biosciences positions in Q4 2015 and 9 closed out, a net change of -4 holders.
  • The largest Assembly Biosciences buyer in Q4 2015 was EcoR1 Capital, an estimated $1.92M added.
  • The largest Assembly Biosciences seller in Q4 2015 was HealthCor Management, an estimated $3.05M sold.

Based on aggregated 13F filings for Q4 2015.